AMAG Pharmaceuticals (NASDAQ: AMAG) will present at the DB 2009 Biotech Boston Confab. The company is scheduled to present on December 15th at 12:30 pm (ET). The company's Executive VP, CFO and Chief Business Officer, David Arkowitz, and Senior VP, Lou Brenner, will host the presentation. A live audio webcast will be available through the Investor Relations section of the company's website. A replay will remain available through December 29, 2009.
MicroCap Insider is a web-based financial portal that publishes a free penny stock newsletter providing stock alerts on companies positioned to deliver high-yield gains to investors. Sign Up for our Free Stock Newsletter
About AMAG Pharmaceuticals, Inc.
AMAG Pharmaceuticals, Inc. is a biopharmaceutical company that utilizes its proprietary technology for the development and commercialization of a therapeutic iron compound to treat iron deficiency anemia and novel imaging agents to aid in the diagnosis of cancer and cardiovascular disease. AMAG recently received approval from the U.S. Food and Drug Administration to market Feraheme ® (ferumoxytol) Injection for the treatment of iron deficiency anemia in adult chronic kidney disease patients.
Investors interested in receiving small cap stock alerts through the penny stock newsletter published by MicroCap Insider can sign up for free by visiting our website
About Us
MicroCap Insider is a leading penny stock web site with extensive experience in the OTC market, providing top stock picks, investing tips and exclusive research on small cap stocks on the verge of producing large financial gains.
Please click here to read the full disclaimer
